On July 9, 2020, ADBiotech Co., Ltd. (XKON:A179530) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,075 KRW | -3.30% |
|
+3.54% | -6.11% |
1st Jan change | Capi. | |
---|---|---|
-6.11% | 21.05M | |
+21.88% | 8.97B | |
+22.25% | 3.66B | |
-4.59% | 3.13B | |
+12.16% | 1.67B | |
-5.18% | 1.25B | |
-30.83% | 1.17B | |
-31.96% | 1.16B | |
-24.53% | 1.01B | |
-13.36% | 931M |
- Stock Market
- Equities
- A179530 Stock
- News ADBiotech Co., Ltd.
- ADBiotech Co., Ltd. announced that it has received KRW 3.0000065 billion in funding from SBI Investment Korea Co., Ltd.